$50 million in Series B investment was secured by SmarterDx, a NYC-based business that specializes in clinical AI for revenue integrity and treatment quality.
Investors
- Transformation Capital
- Bessemer Venture Partners
- Flare Capital Partners
- Floodgate Fund
Use of funds
With the money, the firm plans to expand its customer base to include hospitals and health systems, speed up product creation, add additional clinical and financial data interfaces, improve its in-house algorithms that find new revenue and quality prospects for clients, and expand into new markets.
About SmarterDx
SmarterDx, a clinical AI startup with Dr. Michael Gao as CEO, employs AI to comprehend each patient’s clinical journey and assists hospitals in providing the most accurate and comprehensive narrative possible in order to reduce the revenue integrity “differential” gap. It can be put into use in a matter of weeks, can process over 30,000 data points per graphic, and offers a risk-free return on investment.
“Our goal has always been empowering clinical documentation integrity and coding teams to capture a more accurate, more complete patient picture and enabling providers to focus on patient care rather than paperwork.”
Michael Gao
